Biomarker-Guided cocktail aims to slow kidney failure
Disease control
Recruiting now
This study tests whether using specific biomarkers to choose and combine three kidney-protecting drugs (dapagliflozin, semaglutide, and finerenone) can slow kidney function decline better than standard care. About 125 adults with chronic kidney disease and albuminuria will be ran…
Phase: PHASE4 • Sponsor: Peter Rossing • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC